Robert Otte, MD
Family Medicine · Hebron, KYNPI 1295798791
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 451 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 46 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,429 and has fallen 91.1% since, to $127 in 2025. Among family medicine clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 451 payments — averaging $14.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$648
- Amgen$634
- Novo Nordisk$613
- Pfizer$558
- GSK$484
- plus $2K from 40 others
What the payments were for
- Food & beverage$6,667100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$6,667 in reported general payments places this provider in the 90th percentile of 1,559 family medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 74 | $104,920 |
| TrulicityDulaglutide | 51 | $79,818 |
| JardianceEmpagliflozin | 67 | $74,747 |
| EliquisApixaban | 67 | $67,069 |
| XareltoRivaroxaban | 32 | $34,113 |
| Repatha SureclickEvolocumab | 28 | $28,899 |
| FarxigaDapagliflozin Propanediol | 33 | $25,411 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $21,680 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 18 | $20,745 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $7,550 |
| Levothyroxine Sodium | 613 | $6,539 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 125 | $4,444 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 156 | $4,211 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 39 | $3,720 |
| Atorvastatin Calcium | 770 | $3,647 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $613 | $104,92074 claims |
| Lilly USA, LLCTrulicity | $648 | $79,81851 claims |
| Boehringer IngelheimJardiance | $90 | $74,74767 claims |
| PfizerEliquis | $558 | $67,06967 claims |
| Johnson & JohnsonXarelto | $90 | $34,11332 claims |
| AstraZenecaFarxiga | $209 | $25,41133 claims |
| GSKTrelegy Ellipta | $484 | $21,68033 claims |
| AbbVieSynthroid | $1,300 | $3,20480 claims |
| Almatica Pharma LLCSertraline Hcl | $25 | $1,145132 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Hebron
- Christopher RhyneLouisville$933K
- John RichardLexington$226K
- James TurnboPaducah$124K
- Edward SchumannFlorence$79K
- Ronald KoffNew Castle$71K
- Suraj GathaniLouisville$69K
- Bradley GrayFlorence$51K
- Jackie KazeeAshland$45K
- Mandy WhittLouisville$38K
- Derek JonesAshland$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.